{"lastClose": 1.2000000476837158, "len": 474, "date": "2023-02-03", "alpha_1": -0.9210677675394483, "beta_1": 0.2005307994508698, "drawup_1": 0.7325581218050006, "natr_1": 30.310566852174787, "sup_1": -0.021944475626502803, "res_1": 0.3136110512305212, "bullPattern_1": ["BELTHOLD", "CLOSINGMARUBOZU", "LONGLINE", "MARUBOZU"], "bearPattern_1": [], "rsi_1": 62.34568026149019, "adx_1": 17.995962930114477, "drawdown_1": -0.9065934078890032, "stratHoldSharpe_1": -1.8183016130092113, "stratHoldAlpha_1": 249.73706758521564, "stratHoldDrawdown_1": -0.8178213473962701, "alpha_3mo": -0.7568282116769096, "beta_3mo": -0.6829008302661689, "drawup_3mo": 0.4914914818161982, "natr_3mo": 30.310566852174787, "sup_3mo": -0.03333341611755902, "res_3mo": 0.05833324227068515, "bullPattern_3mo": ["BELTHOLD", "CLOSINGMARUBOZU", "LONGLINE", "MARUBOZU"], "bearPattern_3mo": [], "rsi_3mo": 77.12766097981357, "adx_3mo": 52.49954451002951, "drawdown_3mo": -0.4295301889923263, "stratHoldSharpe_3mo": 1.3299277360097705, "stratHoldAlpha_3mo": 251.96026417835185, "stratHoldDrawdown_3mo": -0.3997501444789029, "Sector": "Health Care", "Name": "LumiraDx Limited", "Market Cap": 298185583, "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Country": "Cayman Islands", "alpha%_1": 0.004499132324597296, "beta%_1": 0.06330295012203048, "drawup%_1": 0.6885464390057305, "natr%_1": 1.0, "drawdown%_1": 0.004768271217152451, "stratHoldSharpe%_1": 0.001520176768235105, "stratHoldAlpha%_1": 4.663131041362562e-08, "stratHoldDrawdown%_1": 0.0060804452558149, "alpha%_3mo": 0.06898997149117014, "beta%_3mo": 0.003633475106118735, "drawup%_3mo": 0.8745254064176942, "natr%_3mo": 1.0, "drawdown%_3mo": 0.002000711033474482, "stratHoldSharpe%_3mo": 0.4595778367800511, "stratHoldAlpha%_3mo": 0.7543916496027162, "stratHoldDrawdown%_3mo": 0.001381995357522178}